PT767172E - 8-arilalquil e 8-aril-heteroalquil-5, 11-di-hidro-6h-dipirido¬3,2-b:2' 3'-e| ¬1,4|diazepinas e a sua utilizacao na prevencao do tratamento da infeccao po hiv - Google Patents

8-arilalquil e 8-aril-heteroalquil-5, 11-di-hidro-6h-dipirido¬3,2-b:2' 3'-e| ¬1,4|diazepinas e a sua utilizacao na prevencao do tratamento da infeccao po hiv

Info

Publication number
PT767172E
PT767172E PT96115901T PT96115901T PT767172E PT 767172 E PT767172 E PT 767172E PT 96115901 T PT96115901 T PT 96115901T PT 96115901 T PT96115901 T PT 96115901T PT 767172 E PT767172 E PT 767172E
Authority
PT
Portugal
Prior art keywords
dihydro
prevention
treatment
hiv infection
heteroalquil
Prior art date
Application number
PT96115901T
Other languages
English (en)
Portuguese (pt)
Inventor
Charles L Cywin
Maryann Hoermann
Janice M Klunder
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PT767172E publication Critical patent/PT767172E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT96115901T 1995-10-06 1996-10-04 8-arilalquil e 8-aril-heteroalquil-5, 11-di-hidro-6h-dipirido¬3,2-b:2' 3'-e| ¬1,4|diazepinas e a sua utilizacao na prevencao do tratamento da infeccao po hiv PT767172E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US480695P 1995-10-06 1995-10-06
US869595P 1995-12-15 1995-12-15

Publications (1)

Publication Number Publication Date
PT767172E true PT767172E (pt) 2003-08-29

Family

ID=26673503

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96115901T PT767172E (pt) 1995-10-06 1996-10-04 8-arilalquil e 8-aril-heteroalquil-5, 11-di-hidro-6h-dipirido¬3,2-b:2' 3'-e| ¬1,4|diazepinas e a sua utilizacao na prevencao do tratamento da infeccao po hiv

Country Status (8)

Country Link
US (1) US5705499A (enExample)
EP (1) EP0767172B1 (enExample)
JP (1) JPH09188680A (enExample)
AT (1) ATE235495T1 (enExample)
DE (1) DE69626915T2 (enExample)
DK (1) DK0767172T3 (enExample)
ES (1) ES2191075T3 (enExample)
PT (1) PT767172E (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747488A (en) * 1996-01-30 1998-05-05 Boehringer Ingelheim Pharmaceuticals, Inc. 2-aryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1, 4!diazepines and their use in the treatment of HIV infection
GB9715584D0 (en) * 1997-07-23 1997-10-01 Eisai Co Ltd Compounds
UA71971C2 (en) 1999-06-04 2005-01-17 Agoron Pharmaceuticals Inc Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
US7141581B2 (en) * 1999-07-02 2006-11-28 Agouron Pharmaceuticals, Inc. Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
TWI262914B (en) * 1999-07-02 2006-10-01 Agouron Pharma Compounds and pharmaceutical compositions for inhibiting protein kinases
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
BR0110302A (pt) 2000-04-18 2003-01-14 Agouron Pharma Compostos de pirazol para inibição de proteìnas cinase, sal e pró-droga farmaceuticamente aceitável, metabólito farmaceuticamente ativo ou sal farmaceuticamente aceitável de metabólito, composição farmacêutica, método de tratamento de condição doentia em mamìferos mediada pela atividade de proteìna cinase, método de modulação ou inibição da atividade de um receptor de proteìna cinase
TWI270547B (en) * 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
SI1294720T1 (sl) * 2000-06-16 2006-08-31 Boehringer Ingelheim Ca Ltd Nenukleozidni inhibitorji reverzne transkriptaze
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) * 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6706706B2 (en) 2002-03-27 2004-03-16 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US6806265B2 (en) * 2002-05-16 2004-10-19 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
DE60306539T2 (de) * 2002-09-19 2007-07-19 Boehringer Ingelheim (Canada) Ltd., Laval Nicht-nukleosidische inhibitoren der reverse transkriptase
WO2004026875A1 (en) * 2002-09-19 2004-04-01 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US7384937B2 (en) 2002-11-06 2008-06-10 Bristol-Myers Squibb Co. Fused heterocyclic compounds and use thereof
EP1610782A1 (en) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
EP1737852A2 (en) * 2004-04-13 2007-01-03 Icagen, Inc. Polycyclic pyridines as potassium ion channel modulators
EP1781300A1 (en) 2004-07-16 2007-05-09 ProteoSys AG Muscarinic antagonists with parp and sir modulatng activity as agents for inflammatory diseases
EP2387405A2 (en) 2009-01-13 2011-11-23 ProteoSys AG Pirenzepine as an agent in cancer treatment
CA2968464A1 (en) 2014-11-25 2016-06-02 Bayer Pharma Aktiengesellschaft Substituted pyridobenzodiazepinone-derivatives and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2183571A1 (en) * 1994-02-18 1995-08-24 Karl D. Hargrave 2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection

Also Published As

Publication number Publication date
DE69626915D1 (de) 2003-04-30
EP0767172A1 (en) 1997-04-09
EP0767172B1 (en) 2003-03-26
US5705499A (en) 1998-01-06
ATE235495T1 (de) 2003-04-15
DE69626915T2 (de) 2003-11-13
JPH09188680A (ja) 1997-07-22
ES2191075T3 (es) 2003-09-01
DK0767172T3 (da) 2003-07-21

Similar Documents

Publication Publication Date Title
ES2191075T3 (es) 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido-(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infecciones por hiv.
EP1131079A4 (en) SMALL FUNCTIONAL UNITS OF THE VARIABLE REGIONS OF THE HEAVY CHAIN OF ANTIBODIES
FI955315A0 (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
ES2130114T3 (es) 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.
FI952302L (fi) Pyran-2-onit ja 5,6-dihydropyranonit, jotka ovat käyttökelpoisia HIV:n ja muiden retrovirusten hoidossa
EP0676954A4 (en) HIV LOCK VIRUS.
PL327061A1 (en) Treatment of hiv infection effects occured in the central nervous system by means o vx-478 preparation used solely or in combination wit azt or 3tc
FR2709754B1 (fr) Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale.
ATE121295T1 (de) Augentropfenarzneimittel.
PT94521A (pt) Processo para a preparacao de 5,11-di-hidro-6h-dipirido-{3,2-b:2',3'-e}{1,4}-diazepino-6-onas e tionas e de composicoes farmaceutica para o tratamento ou a profilaxia da sida
EP1037650A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS
PT1007040E (pt) Utilizacao de fanquinona no tratamento da doenca de alzheimer
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
CA2014885A1 (en) 6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-5-ones and thiones and their use in the prevention or treatment of aids
EP0596680A3 (en) Borazine derivatives of hydridopolysilazane polymers.
DK0451486T3 (da) Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
TW327171B (en) 2-heteroaryl-5 for prevention or treatment of HIV infection
EE03514B1 (et) Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon
NO965591D0 (no) Kombinasjonsbehandling av HIV-infeksjon
GR3015469T3 (en) 5,11-dihydro-6H-pyrido[2,3,-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of AIDS.
ID20165A (id) Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis
KR940021732U (ko) 아동용 신발
IT8721895A0 (it) Policarbonati resistenti alla fiamma, contenenti nella catena polimerica unita' derivanti da composti tetrafenilici monoalogenati.
MX9604346A (es) 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido [3,2-b :2',3'-e] [1,4]diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.
UA972S (uk) Знаки медичні для дитячих медустанов